Skip to main content
CMND
NASDAQ Life Sciences

CMND-100 第一/二期试验显示治疗进展成功，无严重不良事件发生，用于酒精使用障碍

feedReported by GlobeNewswire
Sentiment info
Positive
Importance info
7
Price
$0.677
Mkt Cap
$1.413M
52W Low
$0.595
52W High
$52.4
Market data snapshot near publication time

summarizeSummary

Clearmind Medicine 报告了其 FDA 批准的 CMND-100 第一/二期临床试验的第三组参与者的治疗进展成功，该试验在美国网站进行。该积极的更新是在 3 月 11 日宣布招聘进展之后，强调了继续安全和耐受性，没有报告任何严重不良事件至今。对于一家微型临床阶段生物技术公司，正在进行的试验中积极的进展和安全数据非常重要，为药物候选者的开发提供了信心。投资者将监测未来的试验完成和疗效读数更新。

在该公告发布时，CMND的交易价格为$0.68，交易所为NASDAQ，所属行业为Life Sciences，市值约为$141.3万。 52周交易区间为$0.59至$52.40。 这则新闻被评估为积极市场情绪，重要性评分为7/10。 来源：GlobeNewswire。

show_chartPrice Chart

Share this article

Copied!

feed CMND - Latest Insights

CMND
Apr 27, 2026, 7:45 AM EDT
Filing Type: 6-K
Importance Score:
7
Clearmind Medicine Evaluates Lead Candidate CMND-100 for FDA Breakthrough Therapy Designation
Sentiment: Positive
View Wiseek Article
CMND
Apr 27, 2026, 7:41 AM EDT
Source: GlobeNewswire
Importance Score:
7
Clearmind Medicine Eyes FDA Breakthrough Therapy Designation for CMND-100
Sentiment: Positive
View Wiseek Article
CMND
Apr 21, 2026, 6:57 AM EDT
Filing Type: 6-K
Importance Score:
9
Clearmind Medicine Converts $2.68M in Notes into 4.47M Shares, Causing Significant Dilution
Sentiment: Negative
View Wiseek Article
CMND
Apr 20, 2026, 5:18 PM EDT
Filing Type: 6-K
Importance Score:
9
Clearmind Medicine Secures $2.43M in Highly Dilutive Convertible Note Financing
Sentiment: Negative
View Wiseek Article
CMND
Apr 20, 2026, 4:05 PM EDT
Filing Type: 6-K
Importance Score:
8
Presidential Executive Order Boosts Psychedelic Drug Development, Favors Clearmind's Pipeline
Sentiment: Positive
View Wiseek Article
CMND
Apr 15, 2026, 9:15 AM EDT
Filing Type: 6-K
Importance Score:
8
Clearmind Medicine's CMND-100 Trial Advances to Next Cohort with Increased Dose After Positive DSMB Review
Sentiment: Positive
View Wiseek Article
CMND
Apr 15, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
8
CMND-100 Trial Receives DSMB Approval to Advance, Increase Dose
Sentiment: Positive
View Wiseek Article
CMND
Apr 15, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
8
Clearmind Medicine Converts $1.75M in Notes at $0.60/Share, Causing Significant Dilution
Sentiment: Negative
View Wiseek Article
CMND
Apr 14, 2026, 4:01 PM EDT
Filing Type: 6-K
Importance Score:
9
Clearmind Medicine Secures $1.575M in Highly Dilutive Convertible Note Financing
Sentiment: Negative
View Wiseek Article
CMND
Apr 14, 2026, 8:23 AM EDT
Filing Type: 6-K
Importance Score:
8
Clearmind Medicine's CMND-100 Meets Primary Endpoint in Phase I/IIa AUD Trial
Sentiment: Positive
View Wiseek Article